EdgarLookup
6-K

FORM 6-K

Company
NYMOX PHARMACEUTICAL CORP
Filed
July 20, 2020
Period of Report
July 17, 2020
Accession Number
0001640334-20-001817
View Document ↗ View on SEC.gov ↗